US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Sodium Phosphates Injection 4 mEq/3 mMol/mL

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8077-1 D-0751-2023
Class II · Moderate risk Terminated

Msa 7.84% Msg 8.56%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8029-1 D-0750-2023
Class II · Moderate risk Terminated

vasopressin 50 units added to 0.9% sodium chloride 50 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-9002-1 D-0749-2023
Class II · Moderate risk Terminated

vasopressin 40 units added to 0.9% sodium chloride 100 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-9001-1 D-0748-2023
Class II · Moderate risk Terminated

vasopressin 20 units added to 0.9% sodium chloride 100 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-9000-1 D-0747-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8100-1 D-0746-2023
Class II · Moderate risk Terminated

NORepinephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8097-1 D-0745-2023
Class II · Moderate risk Terminated

NORepinephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8096-1 D-0744-2023
Class II · Moderate risk Terminated

NORepinephrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8095-1 D-0743-2023
Class II · Moderate risk Terminated

EPINEPHrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8093-1 D-0742-2023
Class II · Moderate risk Terminated

tromethamine 0.3 Molar

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8086-2 D-0741-2023
Class II · Moderate risk Terminated

oxyTOCIN 40 units added to 0.9% sodium chloride 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8069-1 D-0740-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-8000-1 D-0739-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7060-1 D-0736-2023
Class II · Moderate risk Terminated

phenylephrine 50 mg added to 0.9% sodium chloride 250 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7039-1 D-0735-2023
Class II · Moderate risk Terminated

NORepinephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7036-1 D-0734-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7025-1 D-0733-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7023-1 D-0732-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7022-1 D-0731-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7019-1 D-0730-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7018-1 D-0729-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-7011-1 D-0727-2023